Raj Kumar

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 16

Top Venues

Journal of medicinal chemistry

RSC medicinal chemistry

Molecules (Basel, Switzerland)

Medicinal research reviews

Central university of Punjab

NIPER (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Central university of Punjab

India

Associate Professor :: Department of Pharmaceutical Sciences and Natural Products

Central University of Punjab Dec 28 2018

India

Professor :: Pharmaceutical Sciences and Natural Products

Education History

NIPER

India

PHD :: Medicinal Chemistry

Publications

Manvendra Kumar, Kiran T Patil, Pritam Maity, Joydeep Chatterjee, Tashvinder Singh, Gaurav Joshi, Sandeep Singh, Raj Kumar
Design, synthesis, and anticancer assessment of structural analogues of ( E )-1-((3,4,5-trimethoxybenzylidene)amino)-4-(3,4,5-trimethoxyphenyl)imidazo[1,2- a ]quinoxaline-2-carbonitrile (6b), an imidazo[1,2- a ]quinoxaline-based non-covalent EGFR inhibitor. RSC medicinal chemistry 15 (7) (2024)
Manvendra Kumar, Kiran T Patil, Pritam Maity, Joydeep Chatterjee, Tashvinder Singh, Gaurav Joshi, Sandeep Singh, Raj Kumar
Design, synthesis, and anticancer assessment of structural analogues of ( E )-1-((3,4,5-trimethoxybenzylidene)amino)-4-(3,4,5-trimethoxyphenyl)imidazo[1,2- a ]quinoxaline-2-carbonitrile (6b), an imidazo[1,2- a ]quinoxaline-based non-covalent EGFR inhibitor. RSC medicinal chemistry 15 (7) (2024)
Pritam Maity, Joydeep Chatterjee, Kiran T Patil, Sahil Arora, Madhurendra K Katiyar, Manvendra Kumar, Amirreza Samarbakhsh, Gaurav Joshi, Priyadeep Bhutani, Manoj Chugh, Navnath S Gavande, Raj Kumar
Targeting the Epidermal Growth Factor Receptor with Molecular Degraders: State-of-the-Art and Future Opportunities. Journal of medicinal chemistry (2023)
Pritam Maity, Joydeep Chatterjee, Kiran T Patil, Sahil Arora, Madhurendra K Katiyar, Manvendra Kumar, Amirreza Samarbakhsh, Gaurav Joshi, Priyadeep Bhutani, Manoj Chugh, Navnath S Gavande, Raj Kumar
Targeting the Epidermal Growth Factor Receptor with Molecular Degraders: State-of-the-Art and Future Opportunities. Journal of medicinal chemistry 66 (5) (2023)
Pritam Maity, Joydeep Chatterjee, Kiran T Patil, Sahil Arora, Madhurendra K Katiyar, Manvendra Kumar, Amirreza Samarbakhsh, Gaurav Joshi, Priyadeep Bhutani, Manoj Chugh, Navnath S Gavande, Raj Kumar
Targeting the Epidermal Growth Factor Receptor with Molecular Degraders: State-of-the-Art and Future Opportunities. Journal of medicinal chemistry 66 (5) (2023)
Pritam Maity, Joydeep Chatterjee, Kiran T Patil, Sahil Arora, Madhurendra K Katiyar, Manvendra Kumar, Amirreza Samarbakhsh, Gaurav Joshi, Priyadeep Bhutani, Manoj Chugh, Navnath S Gavande, Raj Kumar
Targeting the Epidermal Growth Factor Receptor with Molecular Degraders: State-of-the-Art and Future Opportunities. Journal of medicinal chemistry 66 (5) (2023)
Zahid Rafiq Bhat, Manvendra Kumar, Nisha Sharma, Umesh Prasad Yadav, Tashvinder Singh, Gaurav Joshi, Brahmam Pujala, Mohd Raja, Joydeep Chatterjee, Kulbhushan Tikoo, Sandeep Slngh, Raj Kumar
In Vivo Anticancer Evaluation of 6b, a Non-Covalent Imidazo[1,2- a ]quinoxaline-Based Epidermal Growth Factor Receptor Inhibitor against Human Xenograft Tumor in Nude Mice. Molecules (Basel, Switzerland) 27 (17) (2022)
Sahil Arora, Gaurav Joshi, Anuhar Chaturvedi, Michael Heuser, Santoshkumar Patil, Raj Kumar
A Perspective on Medicinal Chemistry Approaches for Targeting Pyruvate Kinase M2. Journal of medicinal chemistry (2021)
Manvendra Kumar, Gaurav Joshi, Sahil Arora, Tashvinder Singh, Sajal Biswas, Nisha Sharma, Zahid Rafiq Bhat, Kulbhushan Tikoo, Sandeep Singh, Raj Kumar
Design and Synthesis of Non-Covalent Imidazo[1,2-a]quinoxaline-Based Inhibitors of EGFR and Their Anti-Cancer Assessment. Molecules (Basel, Switzerland) 26 (5) (2021)
Priyadeep Bhutani, Gaurav Joshi, Nivethitha Raja, Namrata Bachhav, Prabhakar K Rajanna, Hemant Bhutani, Atish T Paul, Raj Kumar
U.S. FDA Approved Drugs from 2015-June 2020: A Perspective. Journal of medicinal chemistry 64 (5) (2021)
Sourav Kalra, Gaurav Joshi, Manvendra Kumar, Sahil Arora, Harsimrat Kaur, Sandeep Singh, Anjana Munshi, Raj Kumar
Anticancer potential of some imidazole and fused imidazole derivatives: exploring the mechanism via epidermal growth factor receptor (EGFR) inhibition. RSC medicinal chemistry 11 (8) (2020)
Iliyas Khan, Gaurav Joshi, Bibekananda Sarkar, Kartik T Nakhate, null Ajazuddin, Anil K Mantha, Raj Kumar, Ankur Kaul, Shubhra Chaturvedi, Anil K Mishra, Umesh Gupta
Doxorubicin and Crocin Co-delivery by Polymeric Nanoparticles for Enhanced Anticancer Potential In Vitro and In Vivo . ACS applied bio materials 3 (11) (2020)
Arshad J Ansari, Gaurav Joshi, Praveen Sharma, Antim K Maurya, Ramesh K Metre, Vijai K Agnihotri, Chanchayya Gupta Chandaluri, Raj Kumar, Sandeep Singh, Devesh M Sawant
Pd-Catalyzed Four-Component Sequential Reaction Delivers a Modular Fluorophore Platform for Cell Imaging. The Journal of organic chemistry 84 (7) (2019)
Gagandeep Kaur, Ravi P Cholia, Gaurav Joshi, Suyog M Amrutkar, Sourav Kalra, Anil K Mantha, Uttam C Banerjee, Raj Kumar
Anticancer activity of dihydropyrazolo[1,5-c]quinazolines against rat C6 glioma cells via inhibition of topoisomerase II. Archiv der Pharmazie 351 (6) (2018)
Gaurav Joshi, Himanshu Nayyar, Sourav Kalra, Praveen Sharma, Anjana Munshi, Sandeep Singh, Raj Kumar
Pyrimidine containing epidermal growth factor receptor kinase inhibitors: Synthesis and biological evaluation. Chemical biology & drug design 90 (5) (2017)
Raj Kumar, Gaurav Joshi, Harveen Kler, Sourav Kalra, Manpreet Kaur, Ramandeep Arya
Toward an Understanding of Structural Insights of Xanthine and Aldehyde Oxidases: An Overview of their Inhibitors and Role in Various Diseases. Medicinal research reviews 38 (4) (2017)

Raj Kumar.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Raj Kumar